Analyze Diet

Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.

Abstract: The plasma and serum concentrations of phenylbutazone (PBZ) and oxyphenbutazone were measured in 158 Thoroughbred horses after various doses of PBZ wer given. All horses were competing or training at racetracks in various parts of the country. All horses used in the study had not been given PBZ 24 hours before they were placed on a specific dosage schedule. Samples were collected 24 hours after the last PBZ administration. Four grams of PBZ were given daily by stomach tube, paste, or tablet for 3 days. On day 4, 24 hours before sample collection, an IV dose of 2 g of PBZ was given, regardless of the dose and method of administration. The 24-hour PBZ plasma concentrations were 3.51, 6.13, and 6.40 micrograms/ml, respectively. After 2 g of PBZ was administered IV daily for 4 days, the plasma PBZ concentration was 4.16 g/ml; after a single 2-g IV administration, the serum concentration was 0.87 g/ml. Concentrations of oxyphenbutazone were 3.35 (stomach tube), 4.29 (paste), 3.60 (tablet), 3.65 (4-day IV), and 1.11 g/ml (single IV). A significant relationship was not found between the serum and the urinary concentrations at this 24-hour measurement. Split samples sent to various laboratories confirmed the stability of high-performance liquid chromatography as a method of analysis.
Publication Date: 1985-04-01 PubMed ID: 4014842
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses a study conducted to measure the levels of phenylbutazone (PBZ) and oxyphenbutazone in the plasma and serum of 158 Thoroughbred racehorses after they were administered different doses of PBZ.

Objective and Methodology of the Study

  • The aim of the research was to observe the plasma and serum concentrations of phenylbutazone (PBZ) and oxyphenbutazone in Thoroughbred racing horses following different dosage regimens.
  • The study comprised 158 Thoroughbred horses that were either competing or training at various racetracks across the country.
  • All the horses selected for the study had not been given any PBZ 24 hours before they were enrolled in the study and assigned a specific dosage schedule.
  • The PBZ was administered via stomach tube, paste, or tablet for three days and on the fourth day, a 2g dose was given intravenously (IV), disregarding the initial dose and the method of administration.
  • 24 hours after the last dose of PBZ was given, samples were collected from the horses to measure the plasma and serum concentrations of PBZ and oxyphenbutazone.

Results of the Study

  • The study found that 24 hours after the last dose, the plasma PBZ concentrations registered at 3.51, 6.13, and 6.40 micrograms/ml when administered via stomach tube, paste, or tablet respectively.
  • When 2g of PBZ was administered intravenously daily for four days, the plasma concentration was 4.16g/ml.
  • Following a single 2-g IV administration, the serum PBZ concentration was at 0.87g/ml.
  • Concentrations of oxyphenbutazone varied depending on the method of administration, with concentrations at 3.35 (stomach tube), 4.29 (paste), 3.60 (tablet), 3.65 (four-day IV), and 1.11 g/ml (single IV).
  • However, no significant correlation was detected between the serum and urine concentrations at this 24-hour measurement.

Validation of Analytical Method

  • The study also confirmed the stability of high-performance liquid chromatography as a method of analysis, via split samples sent off to various laboratories for testing.

Cite This Article

APA
Soma LR, Sams R, Duer W, Tobin T, Woodward C, McDonald J. (1985). Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens. Am J Vet Res, 46(4), 932-938.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 46
Issue: 4
Pages: 932-938

Researcher Affiliations

Soma, L R
    Sams, R
      Duer, W
        Tobin, T
          Woodward, C
            McDonald, J

              MeSH Terms

              • Administration, Oral
              • Animals
              • Chromatography, High Pressure Liquid
              • Dose-Response Relationship, Drug
              • Horses / blood
              • Horses / urine
              • Oxyphenbutazone / administration & dosage
              • Oxyphenbutazone / blood
              • Oxyphenbutazone / urine
              • Phenylbutazone / administration & dosage
              • Phenylbutazone / blood
              • Phenylbutazone / urine
              • Regression Analysis
              • Running